PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel ...

From driving research breakthroughs to bringing new treatments to market, life sciences and business professionals are ...

The Food and Drug Administration says that a prominent medical contrarian and critic of the drug industry will head its ...

Canada], May 29: Mapmygenome, an AI-driven leader in genomics and personalized health, announced the strategic acquisition of ...

Here's our list of the leaders in Massachusetts tech, biotech and climate tech who aren't just surviving, but moving their ...

NORWOOD, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP), a clinical-stage company focused on oncology and obesity, today announced the appointment of ...

In 2025, A-share tech-focused ETFs have continued to attract significant investor interests - the top five industry/thematic ETFs by net inflows ...

"Other than Flagship's fund with the monster Moderna position in 2020-2022, I don't think that's ever been done before in the history of the biotech industry," he said. Atlas' 2022 fund ...

Equity Insider News Commentary – With early onset cancer rates on the rise and funding being cut to NIH, the future for cancer patients is increasingly being shaped not by public institutions, but by ...

Deep tech startups sit at the intersection of breakthrough science and practical innovation. Their technologies often span artificial intelligence, quantum computing, biotech, robotics, and advanced ...

The PGIM Quant Solutions Small-Cap Value Fund underperformed its benchmark, the Russell 2000 Value Index, during Q1 of 2025. Click here to read the full commentary.